PART1 facilitates tumorigenesis and inhibits ferroptosis by regulating the miR-490-3p/SLC7A11 axis in hepatocellular carcinoma
Aging · 31.07.2024 · 16 (14) · 11339-11358
DOI: 10.18632/aging.206009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, online erschienen am 05.07.2024. Verfasst von Decheng Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, China. Hauptthemen laut MEDLINE: Ferroptosis, MicroRNAs, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, China.
- Laboratory of Infection and Immunity, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, China.
- Department of Pharmacy, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, China.
Zitieren
APA
Li, D., Wan, M., Liu, X., Ojha, S. C., Sheng, Y., Li, Y., Sun, C., & Deng, C. (2024). PART1 facilitates tumorigenesis and inhibits ferroptosis by regulating the miR-490-3p/SLC7A11 axis in hepatocellular carcinoma. Aging, 16(14), 11339-11358. https://doi.org/10.18632/aging.206009
Vancouver
Li D, Wan M, Liu X, Ojha SC, Sheng Y, Li Y, et al. PART1 facilitates tumorigenesis and inhibits ferroptosis by regulating the miR-490-3p/SLC7A11 axis in hepatocellular carcinoma. Aging. 2024;16(14):11339-11358. doi:10.18632/aging.206009
BibTeX
@article{Li2024,
author = {Li, Decheng and Wan, Meiling and Liu, Xiaoling and Ojha, Suvash Chandra and Sheng, Yunjian and Li, Yaling and Sun, Changfeng and Deng, Cunliang},
title = {PART1 facilitates tumorigenesis and inhibits ferroptosis by regulating the miR-490-3p/SLC7A11 axis in hepatocellular carcinoma},
journal = {Aging},
year = {2024},
volume = {16},
number = {14},
pages = {11339--11358},
doi = {10.18632/aging.206009}
}
EUVIMED